Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction

INTRODUCTION: Despite the withdrawal of the ABSORB bioresorbable vascular scaffold (BVS) from clinical use, continuous observation of BVS-treated patients is necessary. In the vast majority of clinical trials, patients with ST-segment elevation myocardial infarction (STEMI) were excluded from the an...

Descripción completa

Detalles Bibliográficos
Autores principales: Desperak, Piotr, Hawranek, Michał, Chodór, Piotr A., Świątkowski, Andrzej, Kowalczyk, Jacek, Lekston, Andrzej, Gąsior, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189143/
https://www.ncbi.nlm.nih.gov/pubmed/32368236
http://dx.doi.org/10.5114/aic.2020.93912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189143/
https://www.ncbi.nlm.nih.gov/pubmed/32368236
http://dx.doi.org/10.5114/aic.2020.93912

Ejemplares similares